Novel flavivirus antigens

Details for Australian Patent Application No. 2003267943 (hide)

International Classifications

Event Publications

8 January 2004 Complete Application Filed

Priority application(s): 60/360,030 26.02.02 US

12 February 2004 Application Open to Public Inspection

Published as AU-B-2003267943

6 January 2005 Section 223 Application Allowed

MAXYGEN, INC. The time in which to enter the National Phase has been extended to 26 Oct 2004. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000 2004

16 October 2008 Application Accepted

Published as AU-B-2003267943

15 January 2009 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 15 Dec 2008. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

21 May 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 15 Dec 2008

21 May 2009 Standard Patent Sealed

3 November 2011 Assignment Registered

Maxygen, Inc. The patent has been assigned to AltraVax, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.